What is EHAB's health score?

Enhabit, Inc. (EHAB) has a TradeApes health score of 63 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is EHAB's estimated fair value?

Based on our 5-year discounted cash flow model, Enhabit, Inc.'s estimated fair value is $4.8 per share, representing a -65.2% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is EHAB undervalued or overvalued?

Our model currently rates EHAB as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for EHAB... Refresh in a moment for the full analysis.

Enhabit, Inc. (EHAB)

Healthcare Overvalued low healthy

$13.8

Updated: 2026-06-06

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

60 Healthy

Relative Value

73 Healthy

Capital Allocation

50 Mixed

Risk

70 Healthy

Est. Fair Value $4.8

DCF Upside -65.2%

Sector Rank #1239 of 6820

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.